IP Library Granted Patent US 10,357,650
Granted Patent B2
US 10,357,650 · App. 15/271,940 · Granted Jul 23, 2019

Electrode transition seal for implantable lead body

Inventor: Thomas P. Osypka (Palm Harbor, FL)
Assignee: Oscor Inc.
A61N1/0551
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,357,650
App. No.
15/271,940
Granted
Jul 23, 2019
Kind
B2
Abstract

An implantable stimulation lead is disclosed that includes an elongated lead body having opposed proximal and distal end portions, the lead body being formed from a material having at least one circumferential seal region associated with the distal end portion thereof within which a cylindrical electrode is positioned, the seal region being formed from at least one transition component made from a material that is softer than the material from which the lead body is formed.

Claims (20)

1. An implantable stimulation lead comprising:

an elongated lead body having opposed proximal and distal end portions, the lead body formed from a first material, and having at least one circumferential seal region associated with the distal end portion thereof within which a cylindrical electrode is positioned, the seal region being formed from at least one transition component made from a second material that is softer than the first material from which the lead body is formed, wherein the transition component includes a reduced diameter portion that interacts with the cylindrical electrode and is bounded by enlarged diameter portions that interact with the lead body.

2. An implantable stimulation lead as recited in claim 1 , wherein the distal end portion of the lead body includes a pair of axially spaced apart transition components.

3. An implantable stimulation lead as recited in claim 2 , wherein a cylindrical body spacer is disposed between the pair of axially spaced apart transition components.

4. An implantable stimulation lead as recited in claim 1 , wherein the lead body is formed from a biocompatible polymeric material.

5. An implantable stimulation lead as recited in claim 1 , wherein the at least one transition component is formed from a biocompatible polymeric material.

6. An implantable stimulation lead as recited in claim 1 , wherein the lead body is formed from a polyurethane material.

7. An implantable stimulation lead as recited in claim 1 , wherein the at least one transition component is formed from a silicone material.

8. An implantable stimulation lead as recited in claim 1 , wherein the lead body is formed from a material having a Shore A hardness of about 90.

9. An implantable stimulation lead as recited in claim 1 , wherein the at least one transition component is formed from a material having a Shore A hardness of about 70 or softer.

10. An implantable stimulation lead as recited in claim 1 , wherein the lead body is formed from a biocompatible polymeric material having a relatively hard durometer.

11. An implantable stimulation lead as recited in claim 1 , wherein the lead body is formed from a biocompatible polymeric material having a durometer of relatively medium hardness.

12. An implantable stimulation lead as recited in claim 1 , wherein the cylindrical electrode is formed from Platinum.

13. An implantable stimulation lead as recited in claim 1 , wherein the cylindrical electrode is formed from a Platinum and Iridium alloy.

14. An implantable stimulation lead comprising:

an elongated cylindrical lead body having opposed proximal and distal end portions, and being formed from a first biocompatible polymeric material having a Shore A hardness of about 90, the distal end portion of the lead body including at least one cylindrical transition component that is made from a second biocompatible material having a Shore A hardness of about 70 or softer, wherein the at least one cylindrical transition component has a reduced diameter portion that accommodates a cylindrical electrode and is bounded by enlarged diameter portions that interact with the lead body to provide a smooth transition between the electrode and the lead body.

15. An implantable stimulation lead as recited in claim 14 , wherein the lead body is formed from a polyurethane material.

16. An implantable stimulation lead as recited in claim 14 , wherein the transition component is formed from a silicone material.

17. An implantable stimulation lead as recited in claim 14 , wherein the electrode is formed from Platinum.

18. An implantable stimulation lead as recited in claim 14 , wherein the electrode is formed from a Platinum and Iridium alloy.

Assignments (2)
SECURITY INTEREST Recorded Jan 25, 2022
From: OSCOR INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 058838/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2016
From: OSYPKA, THOMAS P.
To: OSCOR INC.
Reel/Frame 039933/0741 →
Continuity (2)
Provisional Application 62221212 · Sep 21, 2015
Related Publication 20170080215A1 · Mar 23, 2017